Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04DVA
|
||||
| Former ID |
DIB002972
|
||||
| Drug Name |
HAp-IFN
|
||||
| Synonyms |
Hydroxyapatite-IFN (hepatitis C), LTT Bio-Pharma
|
||||
| Indication | HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] | Investigative | [549082] | ||
| Company |
LTT Bio-Pharma Co Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Interferon alpha 2 ligand | Target Info | Modulator | [550872] | |
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Regulation of autophagy | |||||
| PI3K-Akt signaling pathway | |||||
| Toll-like receptor signaling pathway | |||||
| RIG-I-like receptor signaling pathway | |||||
| Cytosolic DNA-sensing pathway | |||||
| Jak-STAT signaling pathway | |||||
| Natural killer cell mediated cytotoxicity | |||||
| Tuberculosis | |||||
| Hepatitis C | |||||
| Hepatitis B | |||||
| Measles | |||||
| Influenza A | |||||
| Herpes simplex infection | |||||
| Autoimmune thyroid disease | |||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | Downstream signaling in naï | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.